An Integrated Approach to MSI-High Colorectal Cancer Therapy in a Young Patient: A Clinical Case.
- 1Department of Oncology, Kazakh Research Institute of Oncology and Radiology (KazIOR), Almaty, Kazakhstan.
- 2Кazakh-Russian Medical University, Almaty, Kazakhstan.
- 3Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Abstract
BACKGROUND Colorectal cancer (CRC) is extremely rare in adolescents and often presents with advanced disease because of nonspecific symptoms. Deficient mismatch repair (dMMR) and microsatellite instability-high (MSI-H) are important biomarkers that influence prognosis, treatment selection, and the need for genetic evaluation. We report the case of an adolescent with MSI-H-associated CRC presenting with acute intestinal obstruction. CASE REPORT A 16-year-old male initially underwent appendectomy for presumed acute appendicitis. Persistent postoperative bowel obstruction prompted computed tomography (CT), revealing a descending colon tumor requiring emergency Hartmann's procedure. Histopathology demonstrated mucinous adenocarcinoma, pT4N0M0, with vascular invasion. Immunohistochemistry showed loss of MSH2/MSH6 expression with retained MLH1/PMS2, indicating dMMR and findings highly suggestive of Lynch syndrome, although germline testing was unavailable. Molecular analysis identified a KRAS mutation without NRAS alterations. Given his multiple high-risk features, including T4 disease, bowel obstruction, vascular invasion, mucinous histology, and very young age, he received 12 cycles of adjuvant FOLFOX chemotherapy. Treatment was well tolerated, and he remains disease-free more than 5 years after completion of therapy. CONCLUSIONS This case highlights the diagnostic complexity of adolescent CRC and the need to consider colorectal malignancy in young patients with persistent or atypical abdominal symptoms. Routine MMR/MSI testing and comprehensive molecular profiling are essential in young-onset CRC to identify patients who may have hereditary cancer syndromes and require genetic counseling. Although limited to a single case, this report underscores the importance of multidisciplinary decision-making and individualized treatment based on clinicopathological and molecular characteristics, which may contribute to favorable long-term outcomes.
Related
- Patient-derived organoids for precision oncology in colorectal cancer: from tumor modeling to clinical translation.
- Large Language Model-derived Symptom Clusters and Patient Outcomes in Colorectal Cancer from MIMIC-IV Clinical Notes
- Immune checkpoint inhibitors combined with VEGF/VEGFR-targeted therapy in microsatellite-stable advanced colorectal cancer: clinical advances and the potential for immune-sensitive tumor conversion
- Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study.
- Integrated scRNA‐Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer‐Associated Fibroblast–Dominant Domains in Colorectal Cancer
BibTeX
@article{turkpenova2026integrated,
title = {{An Integrated Approach to MSI-High Colorectal Cancer Therapy in a Young Patient: A Clinical Case.}},
author = {Innara Turkpenova and Kaldygul Smagulova and Abay Jumanov and Aisha Moldasheva and Rabiga Kadyrbayeva and Azhar Imanaliyeva},
journal = {The American journal of case reports},
year = {2026},
month = oct,
doi = {10.12659/ajcr.953248},
url = {https://europepmc.org/article/MED/42892709},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - An Integrated Approach to MSI-High Colorectal Cancer Therapy in a Young Patient: A Clinical Case.
AU - Innara Turkpenova
AU - Kaldygul Smagulova
AU - Abay Jumanov
AU - Aisha Moldasheva
AU - Rabiga Kadyrbayeva
AU - Azhar Imanaliyeva
PY - 2026
DA - 2026/10/18
JO - The American journal of case reports
DO - 10.12659/ajcr.953248
UR - https://europepmc.org/article/MED/42892709
AB - BACKGROUND Colorectal cancer (CRC) is extremely rare in adolescents and often presents with advanced disease because of nonspecific symptoms. Deficient mismatch repair (dMMR) and microsatellite instability-high (MSI-H) are important biomarkers that influence prognosis, treatment selection, and the need for genetic evaluation. We report the case of an adolescent with MSI-H-associated CRC presenting with acute intestinal obstruction. CASE REPORT A 16-year-old male initially underwent appendectomy for presumed acute appendicitis. Persistent postoperative bowel obstruction prompted computed tomography (CT), revealing a descending colon tumor requiring emergency Hartmann's procedure. Histopathology demonstrated mucinous adenocarcinoma, pT4N0M0, with vascular invasion. Immunohistochemistry showed loss of MSH2/MSH6 expression with retained MLH1/PMS2, indicating dMMR and findings highly suggestive of Lynch syndrome, although germline testing was unavailable. Molecular analysis identified a KRAS mutation without NRAS alterations. Given his multiple high-risk features, including T4 disease, bowel obstruction, vascular invasion, mucinous histology, and very young age, he received 12 cycles of adjuvant FOLFOX chemotherapy. Treatment was well tolerated, and he remains disease-free more than 5 years after completion of therapy. CONCLUSIONS This case highlights the diagnostic complexity of adolescent CRC and the need to consider colorectal malignancy in young patients with persistent or atypical abdominal symptoms. Routine MMR/MSI testing and comprehensive molecular profiling are essential in young-onset CRC to identify patients who may have hereditary cancer syndromes and require genetic counseling. Although limited to a single case, this report underscores the importance of multidisciplinary decision-making and individualized treatment based on clinicopathological and molecular characteristics, which may contribute to favorable long-term outcomes.
SN - 1941-5923
ER -